Governments must show greater concern for how their actions affect public trust, says Vinay Prasad in City Journal. Case in point, the FDA’s near-approval and then subsequent walk-back of the Pfizer vaccine for those aged six months to four years old. The result, observes Prasad, is to erode the FDA’s credibility “at precisely the time we need faith in vaccine regulators.”

Keeping the AI Apocalypse at Bay
Writing in City Journal, Judge Glock examines legal efforts to control AI and dismisses the current fixation on suing for specific harms, such as bad advice. “The idea that we should treat Big Tech, including AI companies, like we treated Big Tobacco, is exactly the wrong idea,” he observes. A better approach is to assess product liability based on which parties can perform the task at the cheapest cost, as is the case with the regulation of medical equipment. This “has the benefit of putting the onus on companies themselves to game out dangerous scenarios and prevent them,” he advises. For more on AI, see this C2C article.


